PXR played a significant role in MDR of breast cancer cells, and treatment with the PXR agonist SR12813 activated and increased PXR protein expression, increased the resistance of cancer cells to chemotherapy drugs and decreased cell apoptosis. The gene discussed is NR1I2; the disease is breast carcinoma.